Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study

Circulating PAI-1 levels are correlated with liver steatosis and, to a lesser extent, fibrosis in apparently healthy patients with a BMI ≥ 25 kg/m<sup>2</sup>. This is the first study to show these results in patients naïve to medications, using FibroScan assessment. The bidirectional relationship between circulating PAI-1 levels and CAP measurement highlights the relevance of our research from a diagnostic and pathophysiological-prognostic viewpoint. Longitudinal trials are needed to clarify the cause-effect association between MASLD and PAI-1 levels.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2025-04-29
DOI
https://doi.org/10.1186/s12967-025-06464-9
Citations
3
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study

Marianna Zappimbulso, Davide Guido, Giovanni De Pergola, Pasqua Letizia Pesole et al.
3 citations
Journal of Translational Medicine
Liver Disease Diagnosis and Treatment
4.06
article

Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study

Marianna Zappimbulso, Davide Guido, Giovanni De Pergola, Pasqua Letizia Pesole, Giuseppe Lisco, Caterina Bonfiglio, Martina Di Chito, Cristiana Randazzo, Sergio Coletta, Domenico Barletta, Gianluigi Giannelli, Endrit Shahini, Rosanna Donvito, Nicole Cerabino, Dolores Stabile, Anna Ancona
article en
3 citations

Abstract

Circulating PAI-1 levels are correlated with liver steatosis and, to a lesser extent, fibrosis in apparently healthy patients with a BMI ≥ 25 kg/m<sup>2</sup>. This is the first study to show these results in patients naïve to medications, using FibroScan assessment. The bidirectional relationship between circulating PAI-1 levels and CAP measurement highlights the relevance of our research from a diagnostic and pathophysiological-prognostic viewpoint. Longitudinal trials are needed to clarify the cause-effect association between MASLD and PAI-1 levels.

Journal of Translational MedicineVol. 23(1)
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT), Gastroenterology Hospital "Saverio de Bellis" (IT), University of Bari Aldo Moro (IT), University of Palermo (IT)
Ministero della Salute
Zero hunger
Openalex Percentile: Top 7%
Liver Disease Diagnosis and Treatment
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.